NCT03350282

Brief Summary

Co-administration of creatine and guanidinoacetic acid (GAA) has been recently put forward as an advanced dietary strategy to optimize tissue bioenergetics. The investigators hypothesized that creatine-GAA mixture would result in more powerful rise in brain and skeletal muscle creatine, as compared to creatine supplementation alone.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2016

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2016

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

November 17, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 22, 2017

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2018

Completed
Last Updated

May 4, 2018

Status Verified

May 1, 2018

Enrollment Period

1.4 years

First QC Date

November 17, 2017

Last Update Submit

May 3, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Brain creatine

    Rise in brain creatine levels

    Baseline vs 4-week follow up

Secondary Outcomes (1)

  • Vastus medialis creatine

    Baseline vs 4-week follow up

Study Arms (2)

Mixture GAA-creatine

EXPERIMENTAL

Mixture of guanidinoacetic acid and creatine monohydrate

Dietary Supplement: GAA-creatine

Creatine

ACTIVE COMPARATOR

Creatine monohydrate

Dietary Supplement: Creatine

Interventions

GAA-creatineDIETARY_SUPPLEMENT
Mixture GAA-creatine
CreatineDIETARY_SUPPLEMENT
Creatine

Eligibility Criteria

Age18 Years - 45 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • men age 18-45 years
  • BMI 18.5-24.9 kg/m2
  • physically active (\> 150 min per week)
  • free of known disease
  • must be able to give written informed consent

You may not qualify if:

  • serum homocysteine \> 15 µmol/L
  • use of dietary supplement (\> 1 month)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Ostojic SM. Co-administration of creatine and guanidinoacetic acid for augmented tissue bioenergetics: A novel approach? Biomed Pharmacother. 2017 Jul;91:238-240. doi: 10.1016/j.biopha.2017.04.075. Epub 2017 Apr 28.

    PMID: 28460226BACKGROUND
  • Semeredi S, Stajer V, Ostojic J, Vranes M, Ostojic SM. Guanidinoacetic acid with creatine compared with creatine alone for tissue creatine content, hyperhomocysteinemia, and exercise performance: A randomized, double-blind superiority trial. Nutrition. 2019 Jan;57:162-166. doi: 10.1016/j.nut.2018.04.009. Epub 2018 May 17.

MeSH Terms

Interventions

Creatine

Intervention Hierarchy (Ancestors)

GuanidinesAmidinesOrganic ChemicalsAmino AcidsAmino Acids, Peptides, and Proteins

Study Officials

  • Sergej Ostojic, MD, PhD

    University of Novi Sad

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 17, 2017

First Posted

November 22, 2017

Study Start

December 1, 2016

Primary Completion

May 1, 2018

Study Completion

May 1, 2018

Last Updated

May 4, 2018

Record last verified: 2018-05

Data Sharing

IPD Sharing
Will share

The data will be shared via institutional repository

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Data will be available from January 2018